OCGN ▲ +2.0% - Ocugen, Inc.
$OCGN - Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU400 to Patients for Treatment of Retinitis Pigmentosa
25-SEP-2026 07:02 AM ET
Share this post
More filings for $OCGN
OCGN ▲ +0.8% - Ocugen, Inc.Sep 1, 2026OCGN - Ocugen, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026OCGN - Ocugen, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026$OCGN SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026
View full $OCGN filing history →💬 Comments
Loading comments…
Leave a comment